Subject ID
|
K306
|
K405
|
KReC51
|
KReC151
|
K093
|
---|
Cohort
|
HIV+ age ≤ 60 months
|
HIV+ age ≤ 60 months
|
KReC
|
KReC
|
HIV+ age > 60 months
|
Sex
|
F
|
F
|
F
|
M
|
F
|
Age (months) at time of sampling
|
18
|
37
|
20
|
15
|
118
|
HIV infection
|
Positive
|
Positive
|
Negative
|
Negative
|
Positive
|
ARTa (if HIV positive)
|
Yes
|
Yes
|
n/a
|
n/a
|
No
|
Number of doses of HBV vaccine
|
NK
|
NK
|
NK
|
3
|
NK
|
HBsAg resultb
|
Detected
|
Detected
|
Detected
|
Not detected
|
Not detected
|
Anti-HBc resultc
|
Not detected
|
Not detected
|
Detected
|
Detected
|
Detected
|
HBeAg resultd
|
Not done
|
Not done
|
Detected
|
Not done
|
Not done
|
Anti-HBs resulte
|
Not detected
|
Not detected
|
Not detected
|
Detected
|
Not detected
|
Interpretation
|
Active infection
|
Active infection
|
Active infection
|
Immunised, infected and cleared
|
Infected and cleared
|
- aART indicates the participant was receiving anti-retroviral therapy to treat HIV infection; bhepatitis B surface antigen test; chepatitis B core antibody test; dhepatitis B envelope antigen test; ehepatitis B surface antibody test (vaccine mediated response). KReC Kimberley Respiratory Cohort, n/a not applicable, NK not known